GR3021117T3 - Promotion of wound-healing with 15-keto-prostaglandin compounds - Google Patents
Promotion of wound-healing with 15-keto-prostaglandin compoundsInfo
- Publication number
- GR3021117T3 GR3021117T3 GR960402483T GR960402483T GR3021117T3 GR 3021117 T3 GR3021117 T3 GR 3021117T3 GR 960402483 T GR960402483 T GR 960402483T GR 960402483 T GR960402483 T GR 960402483T GR 3021117 T3 GR3021117 T3 GR 3021117T3
- Authority
- GR
- Greece
- Prior art keywords
- keto
- wound
- healing
- promotion
- prostaglandin compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7470291 | 1991-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3021117T3 true GR3021117T3 (en) | 1996-12-31 |
Family
ID=13554827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960402483T GR3021117T3 (en) | 1991-03-14 | 1996-09-20 | Promotion of wound-healing with 15-keto-prostaglandin compounds |
Country Status (12)
Country | Link |
---|---|
US (1) | US5252605A (el) |
EP (1) | EP0503887B1 (el) |
JP (1) | JP2515458B2 (el) |
KR (1) | KR100221370B1 (el) |
AT (1) | ATE141794T1 (el) |
AU (1) | AU648877B2 (el) |
CA (1) | CA2062653C (el) |
DE (1) | DE69213057T2 (el) |
DK (1) | DK0503887T3 (el) |
ES (1) | ES2093774T3 (el) |
GR (1) | GR3021117T3 (el) |
NZ (1) | NZ241940A (el) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2107669C (en) * | 1992-02-07 | 2004-06-01 | Makoto Okumura | Preparation for treating wounds and hemorrhoides |
TW420611B (en) * | 1995-03-10 | 2001-02-01 | R Tech Ueno Ltd | Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder |
DE69714698T2 (de) * | 1996-06-10 | 2002-12-05 | Sucampo Ag | Endothelin-antagonisten |
AU739343B2 (en) | 1997-11-28 | 2001-10-11 | Sucampo Ag | Endothelin antagonist |
TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
TWI324589B (en) * | 2001-05-18 | 2010-05-11 | Sucampo Ag | Halogenated bioactive lipid compound |
AR037524A1 (es) * | 2001-11-14 | 2004-11-17 | Sucampo Ag | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion |
US20050124699A1 (en) * | 2002-07-02 | 2005-06-09 | Wakamoto Pharmaceutical Co., Ltd. | Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells |
EP1535617A1 (en) * | 2002-07-02 | 2005-06-01 | Wakamoto Pharmaceutical Co., Ltd. | Remedy or preventive for keratoconjunctival epithelial cell injury |
JP2006522136A (ja) | 2003-04-02 | 2006-09-28 | ネックスメド ホールディングス インコーポレイテッド | プロスタグランジン組成物および血管痙攣の治療のためのその使用 |
EP1853271B1 (en) * | 2005-03-04 | 2010-12-01 | Sucampo AG | Method and composition for treating peripheral vascular diseases |
CA2637275C (en) * | 2006-01-24 | 2014-12-09 | R-Tech Ueno, Ltd. | Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
US8871752B2 (en) * | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
CA2639240A1 (en) * | 2008-08-29 | 2010-02-28 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
US8513441B2 (en) | 2008-08-29 | 2013-08-20 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
WO2010083597A1 (en) * | 2009-01-22 | 2010-07-29 | Apotex Pharmachem Inc. | Methods of making lubiprostone and intermediates thereof |
US8609729B2 (en) * | 2009-04-15 | 2013-12-17 | Sucampo Ag | Method for treating macular degeneration |
CA2838109C (en) | 2011-04-07 | 2020-06-09 | Nexmed Holdings, Inc. | Topical semisolid prostaglandin e1 composition for treating raynaud's disease |
JP6957610B2 (ja) * | 2016-10-06 | 2021-11-02 | スキャンポ・アーゲーSucampo AG | 医薬品用途のための多層ビーズ |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2740953A1 (de) * | 1977-09-12 | 1979-03-22 | Thera Ges Fuer Patente | Verwendung von prostaglandinen zur senkung des blutzuckerspiegels |
EP0153858A3 (en) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | The therapeutic use of prostaglandins |
JPS60208917A (ja) * | 1984-02-29 | 1985-10-21 | ジ・アツプジヨン・カンパニー | Ardsおよび多器官不全治療、予防におけるプロスタグランジンの使用 |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
US5166174A (en) * | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
DE3869471D1 (de) * | 1987-05-15 | 1992-04-30 | Ueno Seiyaku Oyo Kenkyujo Kk | Fiebersteigende zusammensetzung. |
ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
EP0310305B1 (en) * | 1987-10-02 | 1992-07-22 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Cathartics |
JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化 |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
ES2055051T3 (es) * | 1988-05-23 | 1994-08-16 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea. |
JP2579193B2 (ja) * | 1988-07-19 | 1997-02-05 | 小野薬品工業株式会社 | 16,16−ジフルオロ−15−オキソ−15−デオキシpge誘導体 |
-
1992
- 1992-03-10 ES ES92302016T patent/ES2093774T3/es not_active Expired - Lifetime
- 1992-03-10 EP EP92302016A patent/EP0503887B1/en not_active Expired - Lifetime
- 1992-03-10 AT AT92302016T patent/ATE141794T1/de not_active IP Right Cessation
- 1992-03-10 DE DE69213057T patent/DE69213057T2/de not_active Expired - Lifetime
- 1992-03-10 DK DK92302016.8T patent/DK0503887T3/da active
- 1992-03-11 CA CA002062653A patent/CA2062653C/en not_active Expired - Lifetime
- 1992-03-12 US US07/851,283 patent/US5252605A/en not_active Expired - Lifetime
- 1992-03-12 NZ NZ241940A patent/NZ241940A/en not_active IP Right Cessation
- 1992-03-13 KR KR1019920004144A patent/KR100221370B1/ko not_active IP Right Cessation
- 1992-03-13 AU AU12861/92A patent/AU648877B2/en not_active Expired
- 1992-03-13 JP JP4055100A patent/JP2515458B2/ja not_active Expired - Lifetime
-
1996
- 1996-09-20 GR GR960402483T patent/GR3021117T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2062653C (en) | 2002-08-20 |
JP2515458B2 (ja) | 1996-07-10 |
ES2093774T3 (es) | 1997-01-01 |
EP0503887B1 (en) | 1996-08-28 |
NZ241940A (en) | 1997-07-27 |
EP0503887A2 (en) | 1992-09-16 |
KR920017655A (ko) | 1992-10-21 |
DE69213057T2 (de) | 1997-01-09 |
ATE141794T1 (de) | 1996-09-15 |
KR100221370B1 (ko) | 1999-09-15 |
CA2062653A1 (en) | 1992-09-15 |
US5252605A (en) | 1993-10-12 |
DE69213057D1 (de) | 1996-10-02 |
AU648877B2 (en) | 1994-05-05 |
DK0503887T3 (da) | 1996-09-16 |
EP0503887A3 (en) | 1993-01-13 |
JPH0570354A (ja) | 1993-03-23 |
AU1286192A (en) | 1992-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0503887A3 (en) | Promotion of wound-healing with 15-keto-prostaglandin compounds | |
GR3027666T3 (en) | Treatment of cataract with 15-keto-prostaglandin compounds | |
GR3020902T3 (en) | Use of 15-keto-prostaglandin compound for improvement of encephalic function | |
AU549481B2 (en) | Hair growing agent | |
OA09129A (en) | Wound Healing. | |
EP0455448A3 (en) | Treatment of pancreatic disease with 15-keto-prostaglandin compounds | |
EP0467564A3 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
EP0575749A3 (en) | Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers | |
EP0424156A3 (en) | Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds | |
GR3026105T3 (en) | Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds | |
EP0430552A3 (en) | Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds | |
NO993627D0 (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
GR3001277T3 (en) | Chlorpheniramine therapy | |
ES2098325T3 (es) | Tratamiento de cataratas con compuestos de prostaciclina. | |
SE8802040D0 (sv) | New use | |
GR920300126T1 (el) |